Moneycontrol PRO
HomeNewsBusinessPVR Cinemas' Nitin Sood says most landlords waived rents; costs down 75%

PVR Cinemas' Nitin Sood says most landlords waived rents; costs down 75%

PVR CFO Nitin Sood said further cost reductions were not possible, but there was enough liquidity on the company’s balance sheet for now

November 04, 2020 / 12:13 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Multiplex chain PVR managed to reduce losses in the second quarter despite nil revenues from the core movie exhibition business with the exception of one property in Colombo.

    The company managed to get rent waivers from most landlords, PVR’s CFO Nitin Sood said in an interview to CNBC-TV18.

    “The big focus for us right now as revenues have been nil is to really reduce our fixed cost and we have managed to do that,” he said.

    “We have brought down our fixed cost down by almost 75-80 percent. One of the big success that we have also managed to achieve is also to speak to our landlord partners and we have been able to get rent waivers from most of our landlords for the period we have been shut,” he said.

    COVID-19 Vaccine

    Frequently Asked Questions

    View more
    How does a vaccine work?

    A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

    How many types of vaccines are there?

    There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

    What does it take to develop a vaccine of this kind?

    Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

    View more
    Show

    Also Read | PVR shares jump 8% despite reporting Q2 loss of Rs 184 crore

    He said further cost reductions were not possible, but there was enough liquidity on the company’s balance sheet for now.

    Sood said the next major milestone would be the opening up of screens in Maharashtra, which accounts for roughly 25 percent of multiplexes’ revenues.

    “Maharashtra is a very key state for Hindi film releases because it contributes about 20-25 percent of revenue of Hindi film. We are hoping that we will get permission soon to open in Maharashtra,” he said.

    The Maharashtra government has been wary of opening up of cinema halls, fearing a fresh outbreak of COVID-19 cases, especially with the festive season underway.

    Sood said the first six to eight weeks after reopening is expected to be challenging.

    Source: CNBC-TV18

    CNBC-TV18
    first published: Nov 4, 2020 12:13 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347